You searched for "IOL"
Long-term outcomes following surgery for traumatic cyclodialysis clefts
This retrospective case series evaluated the long-term visual prognosis and intraocular pressure control following surgical treatment of traumatic cyclodialysis clefts. Cyclodialysis clefts result from the disinsertion of the longitudinal ciliary muscle fibres from the scleral spur and occur as a...
Risk factors and untreated POAG
The authors examined 50 untreated open angle glaucoma patients to determine if there was an association between the level of glaucomatous damage and documented risk factors. In this study the authors measured the extent of morphologic and functional glaucomatous damage...
Augmented trabeculectomy with mitomycin C in primary congenital glaucoma
This study aimed to determine success of trabeculectomy augmented with mitomycin C (MMC) in children with primary congenital glaucoma (PCG) and document complications of this intervention. Over a two-year period, the authors treated 74 eyes of 42 children with PCG,...
Trial of low-concentration bimatoprost and timolol eye gel versus higher concentrations
This is an international, multicentre, randomised, parallel group, investigator-masked study of 554 patients, having insufficient control of intraocular pressure (IOP) with a first-line monotherapy and requiring dual therapy. Two hundred and eighty patients were randomised to receive low concentration (BTFCEG...PREVIEW: UKISCRS Cornea & Cataract Day
Taking place on Monday 19 May at The Hilton Liverpool (L1 8LW), just a stone's throw away from 2025's RCOphth Annual Congress, you will be able to find the wonderful team from UKISCRS hosting their Cornea & Cataract Day. Our...Biotech Healthcare unveils Optiflex XTENSE Comfort Plus at ESCRS 2025 (Copenhagen), marking a new era in Full Visual Range EDOF IOLs
Biotech Healthcare proudly introduced its newest advancement in intraocular lens technology — Optiflex XTENSE Comfort Plus, a Full Visual Range EDOF IOL, during the ESCRS 2025 meeting in Copenhagen. The product launch at Biotech’s booth drew widespread attention and appreciation...All eyes on the future symposium hailed a great success
Leading providers in the eye healthcare sector, Optegra Eye Health Care and ZEISS, have successfully hosted their annual CPD-accredited symposium, ‘All Eyes on the Future’, bringing together experts from across the ophthalmic sector. The symposium welcomed 90 attendees, including optometrists,...
Eye Healthcare: 90 Years of Progress
Eye Healthcare: 90 Years of Progress by Patrick Condon is far more than a historical account, it is a deeply personal, thoughtful and richly illustrated journey through the most transformative decades in ophthalmology, told by one of Ireland’s most respected...
IVTA use in Behçet’s disease
This study aimed to evaluate the efficacy and safety of intravitreal triamcinolone acetonide (IVTA) injection (4mg/0.1ml) in controlling posterior segment inflammation in patients with Behçet’s disease. Medical records of consecutive patients diagnosed with Behçet’s who underwent IVTA between July 2005...
Ocular hypertension following intravitreal steroid injections: a comparative study between triamcinolone-acetonide and dexamethasone-implant
This was a retrospective observational study of steroid response following 1549 intravitreal steroid (TA and Dex) injections. One thousand and seventy-five eyes of 897 patients were reviewed. Glaucoma patients, glaucoma suspects, uveitis, trauma, and cases with less than one month...
